We are live on
!
Find out more
Temasek Holdings Portfolio holdings
AUM
$30.5B
1-Year Est. Return
13.98%
This Fund
S&P 500
This Quarter
Est. Return
+11.38%
1 Year Est. Return
+13.98%
3 Year Est. Return
+73.05%
5 Year Est. Return
+59.18%
10 Year Est. Return
+409.11%
AUM
$13.4B
AUM Growth
+$916M
(+7.3%)
Cap. Flow
-$310M
Cap. Flow
% of AUM
-2.31%
Top 10 Holdings %
Top 10 Hldgs %
83.18%
Holding
41
New
2
Increased
4
Reduced
4
Closed
1
Top Buys
| 1 |
Gilead Sciences
GILD
|
+$43.2M |
| 2 |
Trip.com Group
TCOM
|
+$23.8M |
| 3 |
Snap
SNAP
|
+$6.65M |
| 4 |
PPG Industries
PPG
|
+$5.99M |
| 5 |
Amazon
AMZN
|
+$2.3M |
Top Sells
| 1 |
Thermo Fisher Scientific
TMO
|
+$196M |
| 2 |
UNVR
Univar Solutions Inc.
UNVR
|
+$120M |
| 3 |
Synchrony
SYF
|
+$40.6M |
| 4 |
Dell
DELL
|
+$23M |
| 5 |
AMRS
Amyris Inc.
AMRS
|
+$5.28M |
Sector Composition
| 1 | Consumer Discretionary | 33.58% |
| 2 | Industrials | 28.93% |
| 3 | Healthcare | 13.56% |
| 4 | Communication Services | 6.88% |
| 5 | Materials | 6.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Mastercard
MA
$480B
| $30M | 0.22% |
267,006
| – | – |
|
|
EMWP
27
DELISTED
Eros Media World PLC
EMWP
| $28.4M | 0.21% |
137,766
| – | – |
|
|
AMRS
28
DELISTED
Amyris Inc.
AMRS
| $27.5M | 0.2% |
3,455,214
-619,567
| -15% | -$5.28M |
|
|
RDS.B
29
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $22.8M | 0.17% |
408,543
| – | – |
|
30
ICICI Bank
IBN
$107B
| $22M | 0.16% |
2,808,988
| – | – |
|
|
JUNO
31
DELISTED
Juno Therapeutics, Inc.
JUNO
| $20.3M | 0.15% |
915,750
| – | – |
|
|
ONC
32
BeOne Medicines Ltd
ONC
$32.4B
| $13.9M | 0.1% |
380,000
| – | – |
|
33
AC Immune
ACIU
$224M
| $13.9M | 0.1% |
1,337,500
| – | – |
|
34
Intellia Therapeutics
NTLA
$1.59B
| $11.1M | 0.08% |
790,527
| – | – |
|
|
35
Snap
SNAP
$7.62B
| $6.76M | 0.05% |
+300,000
| New | +$6.65M |
|
|
MRIN
36
DELISTED
Marin Software
MRIN
| $4.55M | 0.03% |
60,195
| – | – |
|
|
LKM
37
DELISTED
Link Motion Inc.
LKM
| $1.01M | 0.01% |
243,458
| – | – |
|
38
Cognizant
CTSH
$21.2B
| $649K | ﹤0.01% |
10,900
| – | – |
|
39
Senseonics Holdings Inc
SENS
$267M
| $506K | ﹤0.01% |
+14,129
| New | +$682K |
|
|
40
Synchrony
SYF
$24.8B
| – | – |
-1,118,320
| Closed | -$40.6M |
|
Similar funds
Temasek Holdings's Q1 2017 Portfolio in Review
As of Q1 2017, Temasek Holdings held 41 positions worth $13.4B, up 7.3% from $12.5B the previous quarter. Its ten largest holdings account for 83% of the portfolio.
Temasek Holdings's Q1 2017 filing shows 2 new, 4 increased, 4 reduced and 1 closed positions. Its largest new stake was Snap: 300,000 shares worth $6.76M. The largest sale was Thermo Fisher Scientific, an estimated $196M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 34% of assets, up from 29% a quarter earlier, followed by Industrials and Healthcare.
- Temasek Holdings's largest Q1 2017 buy was Snap: 300,000 shares worth $6.76M.
- Temasek Holdings added most to Gilead Sciences in Q1 2017, an estimated $43.2M increase.
- Temasek Holdings's biggest Q1 2017 reduction was Thermo Fisher Scientific, cutting an estimated $196M.
- Temasek Holdings fully exited Synchrony in Q1 2017, selling an estimated $40.6M.
- Temasek Holdings's ten largest holdings make up 83% of its $13.4B portfolio in Q1 2017.
- Temasek Holdings opened 2 new positions and closed 1 in Q1 2017.
- Temasek Holdings's portfolio value rose 7.3% quarter-over-quarter to $13.4B.
Based on Temasek Holdings's 13F filing for Q1 2017, filed 15 May 2017.